Crescent Capital BDC (NASDAQ:CCAP) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.01), Zacks reports. The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%.

Crescent Capital BDC Stock Down 4.8 %

NASDAQ:CCAP opened at $19.05 on Thursday. The firm has a market capitalization of $705.99 million, a PE ratio of 7.45 and a beta of 0.81. The stock has a 50 day moving average of $19.48 and a 200-day moving average of $18.86. Crescent Capital BDC has a 52 week low of $16.38 and a 52 week high of $20.19. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.42 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a dividend yield of 8.82%. Crescent Capital BDC’s dividend payout ratio is 65.88%.

Analysts Set New Price Targets

Several brokerages recently weighed in on CCAP. Wells Fargo & Company boosted their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Wednesday, January 29th. Keefe, Bruyette & Woods boosted their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Check Out Our Latest Stock Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.